These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16827679)

  • 1. Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.
    Wong W; Agrawal N; Pascual M; Anderson DC; Hirsch HH; Fujimoto K; Cardarelli F; Winkelmayer WC; Cosimi AB; Tolkoff-Rubin N
    Transpl Int; 2006 Aug; 19(8):629-35. PubMed ID: 16827679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients.
    Kho MM; Bouvy AP; Cadogan M; Kraaijeveld R; Baan CC; Weimar W
    Transpl Immunol; 2012 Jun; 26(4):186-90. PubMed ID: 22410573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
    Peddi VR; Bryant M; Roy-Chaudhury P; Woodle ES; First MR
    Transplantation; 2002 May; 73(9):1514-8. PubMed ID: 12023634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Different Induction Regimes on Serial Lymphocyte Subsets in Kidney Transplant Recipients: A Single Tertiary Center Experience.
    Jalalonmuhali M; Ng KP; Lee YW; Gan CC; Hing Wong A; Wan Md Adnan WAH; Cheng SF; Chew CC; Ooi SH; Wong CM; Lim SK
    Transplant Proc; 2022 Mar; 54(2):299-306. PubMed ID: 35181166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Thymoglobulin induction in kidney transplantation: an update.
    Mourad G; Morelon E; Noël C; Glotz D; Lebranchu Y
    Clin Transplant; 2012; 26(5):E450-64. PubMed ID: 23061755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of anti-CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25-positive population.
    Sageshima J; Ciancio G; Gaynor JJ; Chen L; Guerra G; Kupin W; Roth D; Ruiz P; Burke GW
    Clin Transplant; 2011; 25(2):E132-5. PubMed ID: 21083765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short course induction immunosuppression with thymoglobulin for renal transplant recipients.
    Agha IA; Rueda J; Alvarez A; Singer GG; Miller BW; Flavin K; Lowell JA; Shenoy S; Howard TK; Ramachandran V; Irish W; Schnitzle MA; Brennan DC
    Transplantation; 2002 Feb; 73(3):473-5. PubMed ID: 11884948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients.
    Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy.
    Serban G; Whittaker V; Fan J; Liu Z; Manga K; Khan M; Kontogianni K; Padmanabhan A; Cohen D; Suciu-Foca N; Ratner L; Colovai AI
    Hum Immunol; 2009 Nov; 70(11):882-90. PubMed ID: 19664673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
    Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients.
    Trullas JC; Cofan F; Cocchi S; Cervera C; Linares L; Aguero F; Oppenheimer F; Moreno A; Campistol JM; Miró JM
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1161-5. PubMed ID: 17961099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
    Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the nuclear factor-κB pathway by rabbit antithymocyte globulins in kidney transplantation.
    Urbanova M; Brabcova I; Girmanova E; Zelezny F; Viklicky O
    Transplantation; 2012 Mar; 93(6):589-96. PubMed ID: 22334040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ; Kerman RH; Zela S; Podbielski J; Podder H; Van Buren CT; Katz S; Kahan BD
    Transplantation; 2006 Apr; 81(8):1101-5. PubMed ID: 16641593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-day induction with thymoglobulin in kidney transplantation: risks and benefits.
    Uslu A; Nart A; Coker I; Köse S; Aykas A; Kahya MC; Yüzbaşioğlu MF; Doğan M
    Transplant Proc; 2004; 36(1):76-9. PubMed ID: 15013305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates.
    Goland S; Czer LS; Coleman B; De Robertis MA; Mirocha J; Zivari K; Schwarz ER; Kass RM; Trento A
    J Heart Lung Transplant; 2008 Oct; 27(10):1115-21. PubMed ID: 18926403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal retransplantation: a retrospective monocentric study.
    Ott U; Busch M; Steiner T; Schubert J; Wolf G
    Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
    Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
    Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation.
    Li L; Chaudhuri A; Chen A; Zhao X; Bezchinsky M; Concepcion W; Salvatierra O; Sarwal MM
    Transplantation; 2010 Dec; 90(12):1516-20. PubMed ID: 20935596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.